Learn more about the EDELWEISS clinical trial!
The EDELWEISS clinical research study is evaluating the safety
and effectiveness of an investigational drug to help reduce endometriosis-related pain.
You may qualify if you are 18 to 49 years old, experience endometriosis-related pain during your period and at other times during your menstrual cycle and have been surgically diagnosed with endometriosis within the last 10 years. You must not currently be pregnant, breastfeeding or planning to become pregnant. Your participation may last up to approximately 15 months and involve approximately 17 study visits. Your participation is voluntary.
To learn more or to see if you qualify for the study, please call
1 (877) 296-6082
Do heavy periods associated with Uterine Fibroids affect you?
Uterine fibroid symptoms can affect any woman, anytime, anywhere. If you’re premenopausal, up to 51 years old, and have heavy periods associated with uterine fibroids, you may qualify for this oral investigational medication study. As a participant, you will receive all study-related care and investigational medication at no cost.
Do you suffer from HEAVY or LONG MENSTRUAL BLEEDING? If yes, you may have UTERINE FIBROIDS
We are looking for volunteers to participate in a new study to test the efficacy of a new investigational drug that targets specific female hormones, to see whether it can help women with Heavy Periods due to Uterine Fibroids.
You may qualify to participate if you:
Are older than 18 years of age
Experience heavy periods every month
Are not breast feeding or wanting to become pregnant
WHAT TO EXPECT:
Study duration of approximately 85 weeks with up to 13 in-clinic visits, plus calls needed
Study medication is an oral tablet taken daily for up to 52 weeks
All study-related care, tests, and study medication will be provided to participants at no cost*
*You do not need health insurance to participate
Qualified participants may receive compensation up to $1540.00 for time and travel costs.